Without being as vague, my main concern is that a pharmaceutical company could find value in business practices that put patients, even those with terminal illn

Without being as vague, my main concern is that a pharmaceutical company could find value in business practices that put patients, even those with terminal illnesses, at an unacceptable risk of harm that the patient may not be cognizant of. If the company begins a campaign of fraudulent kickbacks to healthcare professionals we end up with a corrupt system in which we take advantage of patients and their families. Medicine and medical research goes slowly and cautiously because we wish to protect people. To end this comment, I wish to go back to my statement that if this country goes in the direction of right to try, I sincerely hope lawmakers ensure protection of the patients that could benefit.